DE69726714T2 - 9-oximsilyl erythromycin a derivate - Google Patents

9-oximsilyl erythromycin a derivate Download PDF

Info

Publication number
DE69726714T2
DE69726714T2 DE69726714T DE69726714T DE69726714T2 DE 69726714 T2 DE69726714 T2 DE 69726714T2 DE 69726714 T DE69726714 T DE 69726714T DE 69726714 T DE69726714 T DE 69726714T DE 69726714 T2 DE69726714 T2 DE 69726714T2
Authority
DE
Germany
Prior art keywords
erythromycin
oximsilyl
derivate
alkylerythromycin
oximesilyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69726714T
Other languages
German (de)
English (en)
Other versions
DE69726714D1 (en
Inventor
Yi-Yin Ku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24510750&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69726714(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of DE69726714D1 publication Critical patent/DE69726714D1/de
Publication of DE69726714T2 publication Critical patent/DE69726714T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69726714T 1996-04-02 1997-02-06 9-oximsilyl erythromycin a derivate Expired - Fee Related DE69726714T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/626,524 US5837829A (en) 1996-04-02 1996-04-02 9-oximesilyl erythromycin a derivatives
PCT/US1997/001955 WO1997036913A1 (en) 1996-04-02 1997-02-06 9-oximesilyl erythromycin a derivatives

Publications (2)

Publication Number Publication Date
DE69726714D1 DE69726714D1 (en) 2004-01-22
DE69726714T2 true DE69726714T2 (de) 2004-10-07

Family

ID=24510750

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69726714T Expired - Fee Related DE69726714T2 (de) 1996-04-02 1997-02-06 9-oximsilyl erythromycin a derivate

Country Status (10)

Country Link
US (1) US5837829A (show.php)
EP (1) EP0891371B1 (show.php)
JP (2) JP2000507574A (show.php)
AT (1) ATE256138T1 (show.php)
CA (1) CA2250771C (show.php)
DE (1) DE69726714T2 (show.php)
DK (1) DK0891371T3 (show.php)
ES (1) ES2212808T3 (show.php)
PT (1) PT891371E (show.php)
WO (1) WO1997036913A1 (show.php)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69730138T2 (de) 1996-07-29 2005-03-03 Abbott Laboratories, Abbott Park Herstellung von kristallinen form ii von clarithromycin
US5858986A (en) 1996-07-29 1999-01-12 Abbott Laboratories Crystal form I of clarithromycin
US5945405A (en) 1997-01-17 1999-08-31 Abbott Laboratories Crystal form O of clarithromycin
US20080050367A1 (en) 1998-04-07 2008-02-28 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
WO1999032500A2 (en) * 1997-12-22 1999-07-01 Biochemie S.A. Intermediates in macrolide production
KR100283990B1 (ko) * 1998-12-29 2001-03-02 민경윤 에리스로마이신 a 유도체 및 그의 제조방법
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
GB9915745D0 (en) * 1999-07-06 1999-09-08 Biochemie Sa Organic compounds
KR20020070991A (ko) 1999-12-16 2002-09-11 테바 파마슈티컬 인더스트리즈 리미티드 클라리트로마이신 다형체 및 신규의 다형체 ⅳ의 제조 방법
SI1280535T1 (show.php) 2000-01-11 2005-08-31 Teva Pharma
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
SK13722002A3 (sk) 2000-02-29 2003-08-05 Teva Pharmaceutical Industries Ltd. Spôsob prípravy klaritromycínu a klaritromycínového medziproduktu, v podstate prostého oxímu a farmaceutický prostriedok, ktorý ho obsahuje
KR100367981B1 (ko) * 2000-11-23 2003-01-14 한미약품공업 주식회사 클라리스로마이신 결정형 2의 제조 방법 및 이 방법에사용되는 결정성 클라리스로마이신 메실레이트 삼수화물
RU2230748C2 (ru) * 2000-03-15 2004-06-20 Ханми Фарм. Ко., Лтд. Способ получения кларитромицина в виде кристаллов формы ii
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
CA2533292C (en) 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004258949B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
WO2005009364A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
JP2007502296A (ja) 2003-08-11 2007-02-08 アドバンシス ファーマスーティカル コーポレイション ロバストペレット
EP1653924A4 (en) 2003-08-12 2009-09-09 Middlebrook Pharmaceuticals In ANTIBIOTICS, USE AND FORMULATION ASSOCIATED
AU2004270170B2 (en) * 2003-08-29 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
WO2005027877A1 (en) 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2005269981A1 (en) 2004-07-02 2006-02-09 Bonck, John A Tablet for pulsed delivery
US20060111560A1 (en) * 2004-11-01 2006-05-25 Glenmark Pharmaceuticals Limited Process for the preparation of crystalline form II of clarithromycin
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8784810B2 (en) 2006-04-18 2014-07-22 Janssen Alzheimer Immunotherapy Treatment of amyloidogenic diseases
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
EP2182983B1 (en) 2007-07-27 2014-05-21 Janssen Alzheimer Immunotherapy Treatment of amyloidogenic diseases with humanised anti-abeta antibodies
WO2009023191A2 (en) * 2007-08-09 2009-02-19 Teva Pharmaceutical Industries Ltd. An improved process for the preparation of clarithromycin
JO3076B1 (ar) 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap نظم العلاج المناعي المعتمد على حالة apoe
US9067981B1 (en) 2008-10-30 2015-06-30 Janssen Sciences Ireland Uc Hybrid amyloid-beta antibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
US4640910A (en) * 1985-11-12 1987-02-03 Abbott Laboratories Erythromycin A silylated compounds and method of use
EP0260938B1 (en) * 1986-09-18 1992-12-09 Taisho Pharmaceutical Co. Ltd Erythromycin a derivatives and method for preparing the same
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법

Also Published As

Publication number Publication date
PT891371E (pt) 2004-04-30
CA2250771C (en) 2006-05-02
WO1997036913A1 (en) 1997-10-09
US5837829A (en) 1998-11-17
JP2007224035A (ja) 2007-09-06
ES2212808T3 (es) 2004-08-01
DK0891371T3 (da) 2004-04-13
EP0891371B1 (en) 2003-12-10
EP0891371A1 (en) 1999-01-20
ATE256138T1 (de) 2003-12-15
CA2250771A1 (en) 1997-10-09
DE69726714D1 (en) 2004-01-22
JP2000507574A (ja) 2000-06-20

Similar Documents

Publication Publication Date Title
ATE256138T1 (de) 9-oximsilyl erythromycin a derivate
DE69811120D1 (de) 6-o-alkyl erythronolid-b derivate
FI872093L (fi) Haordmetall med bindemedelsfasgradient och foerfarande foer framstaellning av den.
NO903656L (no) Fremgangsmaate for fremstilling av 17beta-acyl-4-aza-5alfa-androst-1-en-3-oner.
FI931427A0 (fi) Ny onkofetal gen, genprodukt och anvaendningen daerav
GR890100033A (el) Μέ?οδος παρασκευής διδεοξυδιδευδροκαρβοκυκλικών νουκλεοσιδών.
NO872831L (no) FremgangsmŸte for fremstilling av nitrofuranderivater.
EE03679B1 (et) Bensüüleetrite valmistamise protsess
FI882397A0 (fi) Vaccin och framstaellningsfoerfarande.
NO913745L (no) Fremgangsmaate for fremstilling av 1,3-benzoksazinderivater
NO901070L (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
TR23145A (tr) Diflufenican kullanan herbisidal usul
NO901832D0 (no) Fremgangsmaate for fremstilling av polyketon.
NO901071D0 (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
NO871759D0 (no) Fremgangsmaate for fremstilling av sucralfat-preparater.
DE69031181D1 (de) Perylenequinon (UCN-1028D) Derivate
DE69011268D1 (de) Diflourobenzonitril Derivate.
NO900969D0 (no) Fremgangsmaate for fremstilling av anilin-derivat.
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
DE69007317D1 (de) Difluoroalkylcyclohexyl-benzonitril Derivate.
FI971964A0 (fi) Menetelmä 1-halo-3-trialkyylisilasnyylibentseenijohdannaisten valmistamiseksi
NO903196L (no) Fremgangsmaate for fremstilling av 2-diazo-3-trisubstituerte silyloksy-3-butenoater.
NO167387C (no) Fremgangsmaate for fremstilling av 2-guanidinothiazolderivat.
NO890216D0 (no) Fremgangsmaate for revitalisering av forstkulturer.
NO880167D0 (no) Fremgangsmaate for fremstilling av benzotiazindioksyd-derivater.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee